Adverse Drug Reactions Journal
SJR0.125
CN
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.125 | Q4 | 8.8% | |
| 2024 | — | — | 0.127 | Q4 | 13.1% | |
| 2023 | — | — | 0.122 | Q4 | 17.6% | |
| 2022 | — | — | 0.125 | Q4 | 22.4% | |
| 2021 | — | — | 0.115 | Q4 | 21.8% | |
| 2020 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
1008-5734
country
coverage
2020-2026